Clinical trial
Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00181870 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181870 |
|---|---|
| Title | Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder |
| Official title | Open-Label Study of Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Shire Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Mania |
| Intervention type | Drug |
| Interventions | carbamazepine ER (Equetro) |
| Enrollment | 33 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: